KLI
AMPE

Kelman-Lazarov Inc’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Kelman-Lazarov Inc’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8
Closed -$2.25K – 270
2016
Q4 		$2.25K Hold
8
– – ﹤0.01% 284
2016
Q3 		$1.98K Hold
8
– – ﹤0.01% 335
2016
Q2 		$3.23K Hold
8
– – ﹤0.01% 318
2016
Q1 		$7K Buy
+8
New +$5.39K ﹤0.01% 301

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
FPCP
Fort Point Capital Partners San Francisco, California $825M AUM 16.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Kelman-Lazarov Inc's AMPE Position: Q1 2017 in Review

Kelman-Lazarov Inc sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2017, closing a stake of 8 shares — an estimated $2.25K sold.

Kelman-Lazarov Inc first reported a position in AMPE in Q1 2016 and held it in 4 quarters. The position peaked at $7K in Q1 2016. 64 funds tracked by Wall St. Rank hold AMPE as of Q1 2017.

  • Kelman-Lazarov Inc reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2017 after selling out during the quarter.
  • Kelman-Lazarov Inc sold 8 Ampio Pharmaceuticals Inc. shares in Q1 2017, an estimated $2.25K.
  • Kelman-Lazarov Inc first reported a position in Ampio Pharmaceuticals Inc. in Q1 2016 and held it in 4 quarters.
  • Kelman-Lazarov Inc's Ampio Pharmaceuticals Inc. position peaked at $7K in Q1 2016.
  • 64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2017.

Based on Kelman-Lazarov Inc's 13F filing for Q1 2017, filed 25 Apr 2017.